$45 and $43.40 are support areas I'll be watching to add,if in fact in wants to consolidate here. you agree Hale?
no,but Marqibo numbers/guidance can be obtained by following sppi. isn't the tkmr royalty rate mid single digits? i'd expect to see revenues this Q from the channel stocking being done by SPPI
i've re entered in the 46/47 area after years of holding and eventually selling waaay too early in the 30s- my incorrect sell decision(lost 10+ points on re entry cost vs sale price,s/h just held !) was as you point out...frustration with improper management guidance,slower RC execution and IRC issues that never materialized. Scaled down my new position so i can comfortably add on weakness/consolidation, and hold long term as finances ramp in the coming 24 months. I think the #s they will put up w/b shockingly good. Ahhh remembering the $2s of 2007/2008,my panic during the meltdown as was very very heavy here and now the market's new found/growing attention here. no intention of being out of this stock again
Ascending triple top breakout today with P&F showing intermediate target of $68. Agree that a split would be nice to add trading volume/liquidity.
look at growth in backlog,revenue increases, bumped guidance for second half of fiscal year,renewed focus on margins going forward with manufacturing efficiencies ,cost cutting....this is going to $20+. if investors wait for stated financials to catch up they'll miss the anticipatory growth ramp/multiple expansion. Look at growing international business as well.
I see someone else thinking what I'm thinking.Despite being short term overbought a big up move appears in the offing.Whether before Jan who knows,but look at the slow steady institutional accumulation. This week's CC should prove interesting as first Q under 'new' leadership. Sell on the news perhaps given 7 straight up days...if so,good buy op imo collect divvy and patiently await 'da Boyz decision to revalue
they have always been extremely conservative with share issuance...darn, was hoping to buy $43.50 support area. great offering,congrats ADA
giving those caught short going into the surprisingly optimistic CC an opportunity to cover with new found shares,yuck.
nonetheless, a good opportunity also for new buyers to buy the mid 40s b4 the big ramp begins
do some baseline DD...tkmr has an approved product on market(Marqibo-SPPI) and just today announced that partner ALNY has received fast track designation and begun ph3 for another TKMR royalty interest product Patisiran..plus they'll get $5mm of non dilutive $$ from alny any day now upon 1st patient dosing in the Apollo ph3 trial and another $5mm from ALNY for VSP advancement by Ascletis b4 year end.
also btw, expected news released Friday with exercise in full of the OA-more money to tkmr as well as more institutiuonal sponsorship.
I've been patiently awaiting a re entry point,but will not do so until I see under promise and over delivery by management on the financial execution front( or if pps dips toward $30) .This Q will likely disappoint,yet again.I am with Gorak and Hale,management credibility ?s remain. We need this Company to become a profit generating machine to re ramp market cap expansion.